Compare CWD & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CWD | SINT |
|---|---|---|
| Founded | 2009 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0M | 11.1M |
| IPO Year | 2022 | 2007 |
| Metric | CWD | SINT |
|---|---|---|
| Price | $0.53 | $1.64 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $11.00 |
| AVG Volume (30 Days) | ★ 243.2K | 40.3K |
| Earning Date | 05-14-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 59.45 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $20,097,000.00 | $1,018,000.00 |
| Revenue This Year | N/A | $30.26 |
| Revenue Next Year | $19.17 | $413.20 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.43 | $1.40 |
| 52 Week High | $46.21 | $6.78 |
| Indicator | CWD | SINT |
|---|---|---|
| Relative Strength Index (RSI) | 44.57 | 48.08 |
| Support Level | $0.43 | N/A |
| Resistance Level | $1.13 | $1.90 |
| Average True Range (ATR) | 0.06 | 0.13 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 43.38 | 36.59 |
CaliberCos Inc is an asset management firm whose primary goal is to enhance the wealth of investors seeking to make investments in middle-market assets. The company's funds include investment vehicles focused on real estate, private equity, and debt facilities. The company earns asset management fees calculated as a percentage of managed capital in funds and offerings. The company markets services through direct sales to private investors, wholesaling to investment advisers, direct sales to family offices and institutions and through in-house client services. The company operates into three reportable segments: Fund Management, Development, and Brokerage. The majority of revenue is derived from the fund management fees segment.
SINTX Technologies Inc is an advance ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. It provides biomedical solutions for medical devices specializing in silicon nitride (Si3N4) for musculoskeletal and antipathogenic applications. It also manufactures silicon nitride parts for customers in the electrical, aerospace, and other industrial sectors. The company is a globalised leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans. The Company operates as one operating segment.